ID25589A - Senyawa-senyawa amino siklik - Google Patents
Senyawa-senyawa amino siklikInfo
- Publication number
- ID25589A ID25589A IDW20001635A ID20001635A ID25589A ID 25589 A ID25589 A ID 25589A ID W20001635 A IDW20001635 A ID W20001635A ID 20001635 A ID20001635 A ID 20001635A ID 25589 A ID25589 A ID 25589A
- Authority
- ID
- Indonesia
- Prior art keywords
- optionally substituted
- cyclic amino
- cycle compounds
- amino
- preventives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Lubricants (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4692198 | 1998-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID25589A true ID25589A (id) | 2000-10-19 |
Family
ID=12760807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20001635A ID25589A (id) | 1998-02-27 | 1999-02-26 | Senyawa-senyawa amino siklik |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6610708B1 (fr) |
| EP (1) | EP1063230B1 (fr) |
| KR (1) | KR100567950B1 (fr) |
| CN (1) | CN100369896C (fr) |
| AT (1) | ATE238279T1 (fr) |
| AU (1) | AU737303B2 (fr) |
| BR (1) | BRPI9908319B8 (fr) |
| CA (1) | CA2322171C (fr) |
| CZ (1) | CZ300821B6 (fr) |
| DE (1) | DE69907166T2 (fr) |
| DK (1) | DK1063230T3 (fr) |
| ES (1) | ES2196772T3 (fr) |
| HU (1) | HU225741B1 (fr) |
| ID (1) | ID25589A (fr) |
| IL (1) | IL138068A (fr) |
| MX (1) | MXPA00008439A (fr) |
| NO (1) | NO317882B1 (fr) |
| NZ (1) | NZ506574A (fr) |
| PL (1) | PL200666B1 (fr) |
| PT (1) | PT1063230E (fr) |
| RU (1) | RU2203887C2 (fr) |
| TR (1) | TR200002505T2 (fr) |
| WO (1) | WO1999043648A1 (fr) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0416960A (pt) * | 2003-11-28 | 2007-02-21 | Sankyo Co | derivado de amina cìclica tendo anel heteroarila |
| JP2008504279A (ja) * | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
| EA200700117A1 (ru) | 2004-06-24 | 2007-06-29 | Инсайт Корпорейшн | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов |
| TW200720252A (en) * | 2005-05-27 | 2007-06-01 | Sankyo Co | Cyclic amine derivative having substituted alkyl group |
| WO2014037832A2 (fr) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions et méthodes de traitement de l'épilepsie et de maladies neurologiques |
| CA2872975A1 (fr) | 2012-05-07 | 2013-11-14 | Cellixbio Private Limited | Compositions et methodes de traitement de troubles neurologiques |
| US9399634B2 (en) | 2012-05-07 | 2016-07-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of depression |
| AU2013257742A1 (en) | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
| WO2013168022A1 (fr) * | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes pour le traitement de la thrombose athéroscléreuse |
| WO2013167992A1 (fr) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement de troubles inflammatoires |
| US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
| WO2013167991A1 (fr) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement de troubles métaboliques |
| WO2013168025A1 (fr) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement des maladies de coagulation du sang |
| US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
| WO2013168004A2 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement de la douleur fibromyalgique |
| SG11201407318UA (en) | 2012-05-10 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of metabolic syndrome |
| US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
| WO2013168001A1 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement de la douleur modérée à sévère |
| US9242939B2 (en) | 2012-05-10 | 2016-01-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
| WO2013168002A1 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement d'affections neurologiques |
| WO2013167999A2 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement d'affections neurologiques |
| US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
| WO2013168011A1 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et méthodes de traitement de la douleur chronique |
| US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
| US9339484B2 (en) | 2012-05-10 | 2016-05-17 | Cellix Bio Private Limited | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
| US9573927B2 (en) | 2012-05-10 | 2017-02-21 | Cellix Bio Private Limited | Compositions and methods for the treatment of severe pain |
| WO2013168033A1 (fr) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions et methodes pour le traitement de maladies neurologiques |
| SG11201407322QA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of multiple sclerosis |
| JP2015518855A (ja) | 2012-05-23 | 2015-07-06 | セリックスビオ プライヴェート リミテッド | 粘膜炎の治療のための組成物および方法 |
| US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
| CA2873096A1 (fr) | 2012-05-23 | 2013-11-28 | Cellixbio Private Limited | Compositions et methodes pour le traitement d'une maladie inflammatoire de l'intestin |
| US9434729B2 (en) | 2012-05-23 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
| US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
| US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
| US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
| US9624168B2 (en) | 2012-09-06 | 2017-04-18 | Cellix Bio Private Limited | Compositions and methods for the treatment inflammation and lipid disorders |
| SG11201407325YA (en) | 2012-09-08 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for treatment of inflammation and lipid disorders |
| JP6072938B2 (ja) * | 2013-01-09 | 2017-02-01 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | チエノピリジン化合物の混合ジスルフィド結合体およびその使用 |
| US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
| CA2914461A1 (fr) | 2013-06-04 | 2014-12-11 | Cellixbio Private Limited | Compositions et procedes de traitement du diabete et du pre-diabete |
| WO2016110865A1 (fr) | 2015-01-06 | 2016-07-14 | Cellix Bio Private Limited | Compositions et méthodes pour le traitement d'une inflammation et de la douleur |
| US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
| WO2016046835A1 (fr) | 2014-09-26 | 2016-03-31 | Cellix Bio Private Limited | Compositions et méthodes de traitement de l'épilepsie et de troubles neurologiques |
| CN107207403A (zh) | 2014-09-29 | 2017-09-26 | 塞尔利克斯生物私人有限公司 | 用于治疗多发性硬化的组合物和方法 |
| SG11201703369WA (en) | 2014-10-27 | 2017-05-30 | Cellix Bio Private Ltd | Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis |
| US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
| US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
| US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
| US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
| US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
| US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
| US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
| US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
| US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
| SG11201708738YA (en) | 2015-04-30 | 2017-11-29 | Univ Michigan Regents | Mixed disulfide conjugates of thienopyridine compounds and uses thereof |
| CN106554368A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN106554302A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN106554369A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| US11642335B2 (en) * | 2019-09-26 | 2023-05-09 | Board Of Regents, The University Of Texas System | Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs |
| CN111484446A (zh) * | 2020-04-02 | 2020-08-04 | 北京翼方生物科技有限责任公司 | 氯吡格雷代谢活性体二硫衍生物、其制备方法及医药用途 |
| CN111848497A (zh) * | 2020-07-28 | 2020-10-30 | 内蒙古医科大学 | 氯吡格雷活性代谢物衍生物、其前药及其制备方法与应用 |
| CN112851570A (zh) * | 2021-01-13 | 2021-05-28 | 北京沃邦医药科技有限公司 | 不饱和环胺半胱氨酸二硫衍生物制备方法及其医药用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US555854A (en) * | 1896-03-03 | Brush-handle attachment | ||
| US3647796A (en) * | 1968-12-23 | 1972-03-07 | Parke Davis & Co | Cyclicamino alkylaminothioacridine |
| FR2215948B1 (fr) | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
| FR2530247B1 (fr) | 1982-07-13 | 1986-05-16 | Sanofi Sa | Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique |
| FR2576901B1 (fr) | 1985-01-31 | 1987-03-20 | Sanofi Sa | Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique |
| FI101150B (fi) | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
| EP0623120A1 (fr) * | 1992-01-21 | 1994-11-09 | Glaxo Group Limited | Derives d'acide piperidineacetique servant d'inhibiteurs de l'agregation plaquettaire sanguine dependante du fibrinogene |
| ATE181832T1 (de) | 1993-04-23 | 1999-07-15 | Hoechst Ag | Pyrido-pyrimidindione, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| WO1995007691A1 (fr) | 1993-09-17 | 1995-03-23 | Brigham And Women's Hospital | Produits d'addition de l'oxyde nitrique utilises dans la prevention de la thrombose sur des surfaces artificielles et vasculaires |
| NZ334389A (en) | 1996-08-28 | 2001-05-25 | Ube Industries | Cyclic amine derivatives |
-
1999
- 1999-02-26 CZ CZ20003119A patent/CZ300821B6/cs not_active IP Right Cessation
- 1999-02-26 CN CNB998055786A patent/CN100369896C/zh not_active Expired - Lifetime
- 1999-02-26 PL PL342573A patent/PL200666B1/pl unknown
- 1999-02-26 HU HU0100950A patent/HU225741B1/hu unknown
- 1999-02-26 IL IL13806899A patent/IL138068A/xx not_active IP Right Cessation
- 1999-02-26 EP EP99906508A patent/EP1063230B1/fr not_active Expired - Lifetime
- 1999-02-26 ID IDW20001635A patent/ID25589A/id unknown
- 1999-02-26 WO PCT/JP1999/000924 patent/WO1999043648A1/fr active IP Right Grant
- 1999-02-26 TR TR2000/02505T patent/TR200002505T2/xx unknown
- 1999-02-26 BR BRPI9908319-1 patent/BRPI9908319B8/pt not_active IP Right Cessation
- 1999-02-26 RU RU2000122434/04A patent/RU2203887C2/ru active
- 1999-02-26 NZ NZ506574A patent/NZ506574A/xx not_active IP Right Cessation
- 1999-02-26 MX MXPA00008439A patent/MXPA00008439A/es active IP Right Grant
- 1999-02-26 KR KR1020007009485A patent/KR100567950B1/ko not_active IP Right Cessation
- 1999-02-26 AT AT99906508T patent/ATE238279T1/de active
- 1999-02-26 DE DE69907166T patent/DE69907166T2/de not_active Expired - Lifetime
- 1999-02-26 CA CA002322171A patent/CA2322171C/fr not_active Expired - Lifetime
- 1999-02-26 PT PT99906508T patent/PT1063230E/pt unknown
- 1999-02-26 ES ES99906508T patent/ES2196772T3/es not_active Expired - Lifetime
- 1999-02-26 AU AU26413/99A patent/AU737303B2/en not_active Expired
- 1999-02-26 DK DK99906508T patent/DK1063230T3/da active
-
2000
- 2000-08-24 US US09/622,849 patent/US6610708B1/en not_active Expired - Lifetime
- 2000-08-25 NO NO20004279A patent/NO317882B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID25589A (id) | Senyawa-senyawa amino siklik | |
| CA2263983A1 (fr) | Derives cycliques d'amines pour inhiber l'aggregation des thrombocytes | |
| RS51776B (en) | MACROCYCLIC HEPATITIS VIRUS INHIBITORS C | |
| NO20024766D0 (no) | Etyldiaminderivater | |
| ATE161257T1 (de) | Azolylamin-derivat | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| DE69820248D1 (de) | Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben | |
| DK1310502T3 (da) | Phosphonocephem-forbindelse | |
| ATE447560T1 (de) | Amidderivat | |
| CY1107403T1 (el) | Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης | |
| DE60025856D1 (de) | Neue Pseudoerythromycin Derivate | |
| EA200000826A1 (ru) | Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы | |
| DK1485377T5 (da) | Pyranoner egnede som ATM-inhibitorer | |
| ATE237612T1 (de) | Benzofuranderivate | |
| DE69920923D1 (de) | Anthranilsäurederivate | |
| ATE368645T1 (de) | Aminosäurederivate als hiv-protease-inhibitoren | |
| ATE257139T1 (de) | Ein (1'r,2's,5'r)-3-l-menthoxypropan-1-ol, das eine kühlende empfindung erzeugt | |
| ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
| EA200200041A1 (ru) | Новые четвертичные соединения аммония, способ их получения и фармацевтическое применение | |
| SE0201661D0 (sv) | New salts | |
| EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
| SE1050530T5 (sv) | 1-aza-2-alkyl-6-aryl-cykloalkaner anvaendbara som minnesfoerhoejande aemnen | |
| ATE448198T1 (de) | Neue alpha-ketoamidderivate und deren verwendung | |
| ATE462689T1 (de) | Vitamin-d-derivate mit substituenten an der 2- alpha-position | |
| DE50213257D1 (de) | Gabusectin-derivate, verfahren zur deren herstellung und deren verwendung |